KAYA17

0 followers


KAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.

Industries

Stage

Employees

Links

Org chart

Sulatha Dwarakanath, Ph.D.

Collapse
Kevin T. Seltzer
Chief Financial Officer